Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice

被引:12
|
作者
Wu, Hongyan [1 ,2 ]
Yang, Jing [1 ,2 ]
Liu, Yun-Qiang [3 ]
Lei, Song [4 ]
Yang, Mei [4 ]
Yang, Zhi [1 ,2 ]
Yang, Yuan [3 ]
Hu, Zhangxue [1 ,2 ]
机构
[1] Sichuan Univ, Dept Nephrol, West China Hosp, Guoxue Alley,37, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, Natl Clin Res Ctr Geriatr, West China Hosp, Guoxue Alley,37, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, Dept Med Genet, West China Hosp, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Lipoprotein glomerulopathy; ApoE Kyoto (p; R43C); ApoE Sendai (p; R163P); Atherosclerosis; Recombinant adenovirus;
D O I
10.1186/s12967-021-02765-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai. Method Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (-/-) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto, apoE3, and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin-creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed. Results After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4-6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 +/- 3.1 mu g/mL vs.: 22.2 +/- 4.5 mu g/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 mu g/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin-creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (-/-) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation. Conclusions In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
    Hongyan Wu
    Jing Yang
    Yun-Qiang Liu
    Song Lei
    Mei Yang
    Zhi Yang
    Yuan Yang
    Zhangxue Hu
    Journal of Translational Medicine, 19
  • [2] Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice
    Atsunori Ishimura
    Maho Watanabe
    Hitoshi Nakashima
    Kenji Ito
    Katsuhisa Miyake
    Shizue Mochizuki
    Yasushi Ishigaki
    Takao Saito
    Clinical and Experimental Nephrology, 2009, 13 : 430 - 437
  • [3] Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice
    Ishimura, Atsunori
    Watanabe, Maho
    Nakashima, Hitoshi
    Ito, Kenji
    Miyake, Katsuhisa
    Mochizuki, Shizue
    Ishigaki, Yasushi
    Saito, Takao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2009, 13 (05) : 430 - 437
  • [4] APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy
    Rovin, Brad H.
    Roncone, Daniel
    McKinley, Alison
    Nadasdy, Tibor
    Korbet, Stephen M.
    Schwartz, Melvin M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (24): : 2522 - 2524
  • [5] Virus-mediated transduction of apolipoprotein E (ApoE)-Sendai develops lipoprotein glomerulopathy in ApoE-deficient mice
    Ishigaki, Y
    Oikawa, S
    Suzuki, T
    Usui, S
    Magoori, K
    Kim, DH
    Suzuki, H
    Sasaki, J
    Sasano, H
    Okazaki, M
    Toyota, T
    Saito, T
    Yamamoto, TT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 31269 - 31273
  • [6] Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice
    Wu, Jianhua
    Xiao, Yanhong
    Liu, Juang
    Yang, Hong
    Dong, Xiaomin
    Hu, San
    Jin, Shanrui
    Wu, Dongfang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (02) : 462 - 468
  • [7] Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation
    Hu, Zhangxue
    Huang, Songmin
    Wu, Yu
    Liu, Yunqiang
    Liu, Xiaoxia
    Su, Dan
    Tao, Ye
    Fu, Ping
    Zhang, Xiuhui
    Peng, Ziying
    Zhang, Sizhong
    Yang, Yuan
    KIDNEY INTERNATIONAL, 2014, 85 (02) : 416 - 424
  • [8] Normolipidemic lipoprotein glomerulopathy with IgA nephropathy - ApoE Kyoto mutation: a case report
    Yi, Xiangling
    Bai, Lihua
    Chen, Kehong
    He, Yani
    Chen, Jia
    DIAGNOSTIC PATHOLOGY, 2025, 20 (01)
  • [9] Biologic activity of an apoE synthetic peptide in apoE-deficient mice
    Curtiss, LK
    Nikoulin, I
    CIRCULATION, 1997, 96 (08) : 1936 - 1936
  • [10] Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation
    Ryosuke Usui
    Masaki Takahashi
    Kosaku Nitta
    Minako Koike
    CEN Case Reports, 2016, 5 (2) : 148 - 153